Predictors of Drug Resistance or Negative Culture at Baseline:
Identifying Ineligible Patients in a Clinical Trial for
Tuberculosis Treatment
1 of 5
Approval Sheet Risk Factors for Poor Treatment Outcomes
among Patients with Multi-Drug Resistant and Extensively
Drug-Resistant (M/XDR) Tuberculosis in the Country of Georgia.
2 of 5
Concordance between programmatically- and laboratory-determined
treatment outcomes for multidrug-resistant tuberculosis patients in
Peru
3 of 5
EFFECTIVENESS OF PROVIDING A WRITTEN REFERRAL TO NEWLY ARRIVING
IMMIGRANTS AT FIRST PORT OF ENTRY ON THE COMPLETION OF U.S. TB
EVALUATIONS
4 of 5
Diagnosis of Latent Tuberculosis Infection among HIV discordant
partners using Interferon-Gamma Release Assays (IGRAs).